Professor Suji Park of Hwasun Jeonnam National University Hospital Presents Treatment Strategy for Cystic Metastatic Brain Tumors

Awarded "Best Paper" at the Annual Academic Conference

Professor Suji Park, Hwasun Jeonnam National University Hospital.

The research of Professor Suji Park from the Department of Neurosurgery at Hwasun Jeonnam National University Hospital is drawing attention for presenting an optimal treatment strategy for patients with cystic metastatic brain tumors using Gamma Knife surgery.

Hwasun Jeonnam National University Hospital announced on the 25th that Professor Suji Park from the Department of Neurosurgery received the Best Paper Award at the 24th Annual Meeting of the Gamma Knife Radiosurgery Society for her study titled "Treatment outcome of Stereotactic Radiosurgery in Cystic Metastatic Brain Tumors."

Professor Park analyzed years of accumulated clinical data to determine how the cystic ratio and size within the tumor, as well as the radiation dose, affect treatment outcomes.

The results revealed that maintaining a sufficient radiation dose is key to tumor control, and that the smaller the tumor size, the higher the treatment effectiveness.

Professor Park explained that for large cystic tumors, Gamma Knife treatment alone may have limited efficacy, so it is important to reduce the tumor size through cyst aspiration prior to the procedure.

Furthermore, if a significant amount of tumor remains after aspiration, she confirmed that 'fractionated Gamma Knife radiosurgery (fractionated GKRS),' in which radiation is delivered in multiple sessions, is a safe and effective method.

Professor Suji Park stated, "This research is meaningful in that it summarizes the optimal strategy for treating cystic metastatic brain tumors based on actual patient data," adding, "I hope it will be utilized for more precise and safer personalized radiation therapy in clinical practice going forward."

The conference review panel highly evaluated the study's clinical applicability, completeness of data, and its potential to improve future treatment guidelines, selecting it as the best paper.

Meanwhile, the Gamma Knife Center at Hwasun Jeonnam National University Hospital is leading non-invasive treatments for brain tumors and cerebrovascular diseases, based on state-of-the-art equipment and extensive clinical experience.

Since its opening in 2004, the center has established itself as a top-tier institution in Korea, providing safe and precise personalized treatments to both domestic and international patients, with over 6,000 successful surgeries performed to date.

This content was produced with the assistance of AI translation services.